Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
11983393 Canada was a Canadian private corporation incorporated in March 2020 and dissolved in April 2021. Available public records indicate it operated under the names Project Oasis and Canada COVID19 Data Clearinghouse, and received Canadian government support for a platform intended to help government subject matter experts share key knowledge during the COVID-19 response. The company appears to have been a health data or digital health initiative rather than a therapeutics developer, with no evidence of a drug pipeline, proprietary therapeutic assets, or clinical-stage programs. Its known activity was tied to pandemic-era information sharing and data infrastructure rather than biotech R&D, pharma development, or healthcare product commercialization. Based on currently available evidence, it should be treated as a dissolved Canadian corporation with limited publicly disclosed operating history.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 11983393 Canada.